Cargando…
Thyroid malignant neoplasm-associated biomarkers as targets for oncolytic virotherapy
Biomarkers associated with thyroid malignant neoplasm (TMN) have been widely applied in clinical diagnosis and in research oncological programs. The identification of novel TMN biomarkers has greatly improved the efficacy of clinical diagnosis. A more accurate diagnosis may lead to better clinical o...
Autores principales: | Guan, Mingxu, Ma, Yanping, Shah, Sahil Rajesh, Romano, Gaetano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996252/ https://www.ncbi.nlm.nih.gov/pubmed/27579295 http://dx.doi.org/10.2147/OV.S99856 |
Ejemplares similares
-
Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm
por: Guan, Mingxu, et al.
Publicado: (2014) -
Oncolytic Virotherapy for Hematological Malignancies
por: Bais, Swarna, et al.
Publicado: (2012) -
ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012) -
Oncolytic virotherapy for pediatric malignancies: future prospects
por: Waters, Alicia M, et al.
Publicado: (2016) -
Oncolytic Virotherapy and Microenvironment in Multiple Myeloma
por: Marchica, Valentina, et al.
Publicado: (2021)